Acadia Healthcare (NASDAQ:ACHC) Stock Price Up 7.4% - Here's What Happened

Key Points

• Acadia Healthcare shares jumped 7.4% to about $32.08 in mid-day trading, although volume was 94% below the stock’s average session volume.
• Analyst views remain mixed: UBS raised its target to $39 and maintained a “buy” rating, while Barclays, Cantor Fitzgerald and others remained neutral. The consensus rating is “Hold”, with an average price target of $29.85.
• Acadia’s latest quarterly results beat estimates, with EPS of $0.38 versus $0.35 expected and revenue of $865.84 million versus $844.19 million forecast. However, revenue declined 0.4% year over year and the company reported a negative net margin.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report)'s stock price rose 7.4% during mid-day trading on Wednesday . The company traded as high as $32.87 and last traded at $32.0820. 194,755 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 3,182,073 shares. The stock had previously closed at $29.87.

Analysts Set New Price Targets

Several analysts recently commented on ACHC shares. Weiss Ratings restated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Barclays raised their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a research report on Thursday, July 30th. UBS Group upped their price target on Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 9th. Jefferies Financial Group raised Acadia Healthcare from a "hold" rating to a "buy" rating and raised their price objective for the company from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, Cantor Fitzgerald reaffirmed a "neutral" rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Acadia Healthcare has an average rating of "Hold" and an average price target of $29.85.

Acadia Healthcare Stock Performance

The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm has a market cap of $2.96 billion, a PE ratio of -2.55, a P/E/G ratio of 9.25 and a beta of 0.64. The firm has a 50-day moving average price of $30.14 and a two-hundred day moving average price of $25.81.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. During the same quarter last year, the firm posted $0.83 EPS. The firm's revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. EverSource Wealth Advisors LLC lifted its position in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after buying an additional 497 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of Acadia Healthcare by 208.9% in the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company's stock valued at $32,000 after purchasing an additional 1,510 shares during the period. Allworth Financial LP purchased a new position in Acadia Healthcare during the second quarter worth about $45,000. Global Retirement Partners LLC purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $68,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Acadia Healthcare by 4,264.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company's stock valued at $76,000 after buying an additional 5,203 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source